Growth Metrics

ENDRA Life Sciences (NDRA) Other Working Capital Changes (2016 - 2021)

Historic Other Working Capital Changes for ENDRA Life Sciences (NDRA) over the last 6 years, with Q4 2021 value amounting to $1.7 million.

  • ENDRA Life Sciences' Other Working Capital Changes rose 14255.26% to $1.7 million in Q4 2021 from the same period last year, while for Dec 2021 it was $957203.0, marking a year-over-year increase of 24927.91%. This contributed to the annual value of -$255913.0 for FY2024, which is 5291.17% down from last year.
  • Per ENDRA Life Sciences' latest filing, its Other Working Capital Changes stood at $1.7 million for Q4 2021, which was up 14255.26% from -$208278.0 recorded in Q3 2021.
  • ENDRA Life Sciences' Other Working Capital Changes' 5-year high stood at $1.7 million during Q4 2021, with a 5-year trough of -$1.2 million in Q2 2020.
  • For the 5-year period, ENDRA Life Sciences' Other Working Capital Changes averaged around $83223.0, with its median value being $11344.5 (2018).
  • In the last 5 years, ENDRA Life Sciences' Other Working Capital Changes crashed by 1648678.82% in 2017 and then surged by 961338.25% in 2020.
  • ENDRA Life Sciences' Other Working Capital Changes (Quarter) stood at -$33757.0 in 2017, then skyrocketed by 95.6% to -$1484.0 in 2018, then soared by 1014.22% to $13567.0 in 2019, then surged by 5198.56% to $718856.0 in 2020, then surged by 142.55% to $1.7 million in 2021.
  • Its last three reported values are $1.7 million in Q4 2021, -$208278.0 for Q3 2021, and -$963415.0 during Q2 2021.